Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Psoralen--long-wave ultraviolet therapy and human cataractogenesis

Journal Article · · Invest. Ophthalmol. Visual Sci.; (United States)
OSTI ID:6239935

Cataract formation associated with psoralen--long-wave ultraviolet (P-UVA) therapy has been documented in experimental animals. Presumptive P-UVA cataracts in humans have also been reported recently. Cataracts from two patients on P-UVA therapy were subjected to high-resolution phosphorescence spectroscopy. The lens homogenates from these two patients showed phosphorescence peaks identical (in shape and lifetime) with the previously reported 8-methoxypsoralen lens protein photoproduct seen in P-UVA-treated cataractous rat lenses. The data provide objective proof that these phototherapeutic drugs can generate specific P-UVA photoproducts in human lenses. Similar photoproducts have previously been demonstrated in experimental (rat) P-UVA cataracts.

Research Organization:
Department of Ophthalmology, Emory University, Atlanta, GA
OSTI ID:
6239935
Journal Information:
Invest. Ophthalmol. Visual Sci.; (United States), Journal Name: Invest. Ophthalmol. Visual Sci.; (United States) Vol. 23:6; ISSN IOVSD
Country of Publication:
United States
Language:
English